INPEFA 400 mg/1
sotagliflozin · TABLET · Lexicon Pharmaceuticals, Inc.
INPEFA is a tablet containing sotagliflozin at 400 mg/1, taken oral. Manufactured by Lexicon Pharmaceuticals, Inc..
Key Facts
- Brand Name
- INPEFA
- Generic Name
- sotagliflozin
- NDC Code (Product)
70183-241- Manufacturer
- Lexicon Pharmaceuticals, Inc.
- Strength
- 400 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA216203
- Drug Class
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
- Marketing Start
- 05/26/2023
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is INPEFA used for?
INPEFA contains sotagliflozin. It is a tablet taken oral. Consult your doctor for specific uses.
Is INPEFA a controlled substance?
INPEFA is not classified as a controlled substance by the DEA.
What is the generic name for INPEFA?
The generic name for INPEFA is sotagliflozin. There are no other listed brand versions of sotagliflozin.
What is the NDC code for INPEFA 400 mg/1?
The NDC (National Drug Code) for INPEFA 400 mg/1 is 70183-241, listed by Lexicon Pharmaceuticals, Inc..
Other INPEFA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)